Sleep terrors [night terrors]

F5_SLEEPTERRORS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F51.4 Cause of death: ICD-10 — F51.4 2 out of 7 registries used, show all original rules.	85
4. Check minimum number of events None	85
5. Include endpoints None	85
6. Filter based on genotype QC (FinnGen only)	78

Control definitions (FinnGen only)

Control exclude: F5_SLEEP

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	F5_SLEEPTERRORS
CONTROL_EXCLUDE	F5_SLEEP
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F514
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F514
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sleep terrors [night terrors] based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1681	662	1017
Only index persons	1307	520	787
Unadjusted period prevalence (%)
Whole population	0.02	0.02	0.03
Only index persons	0.03	0.02	0.03
Median age at first event (years)
Whole population	6.64	6.09	6.94
Only index persons	7.71	7.32	7.97

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	78	60	18
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	15.41	17.22	9.36

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
85: Matched controls
850

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

+∞

122.4

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

27.6

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

+∞

11.7

G47.9

ICD-10 Finland

Sleep disorder, unspecified

22.4

10.7

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

37.8

10.7

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

+∞

8.5

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

+∞

7.4

Z01.8

ICD-10 Finland

Other specified special examinations

4.0

7.0

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

+∞

6.3

R51.80

ICD-10 Finland

Headache

3.4

6.2

112

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

255

2.63

4.57

2.7

2.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

147

2.75

4.48

2.0

1.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.99

4.10

3.2

3.0

1.06

0.55

e6/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

151

2.52

3.76

4.2

3.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

183

2.43

3.69

6.1

3.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

4.33

3.66

1.8

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

275

2.35

3.66

3.3

2.6

—

(3011288) Drugs identified in Urine by Screen method

3.05

3.46

2.8

2.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2.67

3.37

1.2

1.3

53.10

13.07

iu/ml

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.70

3.32

2.9

3.1

2.56

4.08

e6/l

—

(3044889) 12 lead EKG panel

293

2.24

3.29

3.2

2.5

—

(36304419) Bacteria [Presence] in Urine

161

2.33

3.21

6.2

2.8

—

(40768797) Stomach Pathology biopsy report

3.23

3.18

1.4

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

282

2.16

3.03

2.7

1.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

321

2.14

2.93

6.0

4.4

0.00

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

322

2.13

2.90

4.8

3.1

0.00

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

325

2.10

2.80

5.0

3.2

0.00

estimate

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2.42

2.70

1.4

1.3

16.45

8.35

u/ml

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

172

2.15

2.68

2.6

1.7

94.91

88.62

pmol/l

0.35

101

(3007853) Bacteria identified in Skin by Aerobe culture

2.62

2.68

1.9

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

157

2.17

2.64

6.5

2.9

0.10

0.23

e6/l

0.59

116

(3002582) Erythrocytes [#/volume] in Urine

173

2.13

2.64

6.1

2.9

20.27

70.16

e6/l

0.78

129

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

199

2.08

2.58

3.8

3.5

22.67

28.63

u/l

1.90

191

(40768804) Tissue Pathology biopsy report

199

2.08

2.58

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

177

2.07

2.47

2.3

2.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

309

1.97

2.41

4.0

7.3

—

(3001604) Monocytes [#/volume] in Blood

328

1.97

2.40

4.2

6.6

0.55

0.54

e9/l

0.05

288

(3006315) Basophils [#/volume] in Blood

328

1.97

2.40

4.2

6.6

0.04

e9/l

0.29

288

(3019198) Lymphocytes [#/volume] in Blood

351

1.94

2.28

4.1

6.5

1.95

2.10

e9/l

0.73

318

(3000850) Epithelial cells [#/volume] in Urine

119

2.15

2.24

6.1

2.2

10.45

9.11

e6/l

0.17

104

(3018095) Leukocytes [#/volume] in Urine

218

1.93

2.18

6.8

3.4

19.43

71.63

e6/l

1.14

138

(40761535) Cells panel - Urine sediment

2.92

2.15

4.0

3.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

3.12

2.14

1.6

2.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2.39

2.13

1.6

2.1

338.33

378.38

nmol/l

0.35

(4200892) Spirometry reversibility

3.02

2.07

1.4

1.2

—

(3013115) Eosinophils [#/volume] in Blood

341

1.85

2.02

5.0

7.6

0.14

0.17

e9/l

1.49

306

(3016879) Cocaine [Presence] in Urine

2.19

1.97

2.3

2.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

149

1.96

1.95

2.0

1.9

2.93

2.64

mg/l

0.19

126

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

4.35

1.85

1.0

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.42

1.84

1.2

1.6

—

(3027008) Opiates [Presence] in Urine

2.09

1.83

2.2

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.27

1.82

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

2.06

1.79

2.2

2.1

—

(3028300) Cannabinoids [Presence] in Urine

2.06

1.79

2.2

2.1

—

(3027944) Amphetamines [Presence] in Urine

2.06

1.79

2.2

2.1

—

(1002224) Polysomnography panel

3.50

1.78

1.0

1.1

—

(3042936) Bacteria identified in Isolate by Culture

2.29

1.76

1.7

2.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

4.01

1.74

13.8

21.5

1.35

1.12

mg/l

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

148

1.87

1.68

4.4

2.9

50.25

55.37

u/l

0.48

139

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

217

1.76

1.65

7.2

9.6

1.21

1.22

mmol/l

0.21

183

(3037467) Urinalysis macro (dipstick) panel - Urine

465

1.78

1.65

6.3

3.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.47

1.54

1.0

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

128

1.85

1.51

4.0

2.2

9.91

12.18

ng/l

—

(3026782) Osmolality of Urine

113

1.88

1.47

6.7

2.4

539.50

585.73

mosm/kgh2o

0.38

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2.85

1.46

1.3

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

130

1.82

1.44

3.2

2.4

21.77

63.75

ug/g

2.12

(3013650) Neutrophils [#/volume] in Blood by Automated count

375

1.64

1.41

7.9

9.2

4.18

3.89

e9/l

0.35

327

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2.28

1.38

2.7

4.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

682

2.08

1.38

4.3

4.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

3.06

1.38

1.8

1.1

—

(40758558) Short blood count panel - Blood

174

1.71

1.37

7.7

6.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.98

1.35

2.5

2.3

—

(3025941) Bacteria identified in Stool by Culture

2.49

1.33

1.1

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.11

1.29

1.1

1.6

—

(40761511) CBC panel - Blood by Automated count

713

2.14

1.23

12.1

7.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2.22

1.22

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

327

1.56

1.19

3.6

6.4

6.04

6.33

mmol/l

0.40

285

(3044640) Blood type and Crossmatch panel - Blood

163

1.66

1.19

2.3

2.2

—

(3019060) Gas panel - Arterial blood

2.59

1.17

1.6

29.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.59

1.17

1.0

1.2

—

(3045414) Leukocytes [Presence] in Urine

2.29

1.11

1.9

1.5

—

(3000494) Fungus identified in Specimen by Culture

1.87

1.10

1.5

1.7

—

(3022145) Colonoscopy Study observation

2.12

1.09

1.6

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

2.02

1.06

2.7

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.35

1.05

1.0

1.2

—

(3023368) Bacteria identified in Blood by Culture

109

1.70

1.03

4.5

3.6

—

(3021589) Normoblasts [#/volume] in Blood

317

1.49

1.00

6.4

8.3

0.00

e9/l

-0.00

254

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.79

0.98

1.2

1.7

—

(3026008) Bacteria identified in Urine by Culture

207

1.53

0.97

3.0

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.31

0.95

1.5

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.23

0.93

5.5

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

121

1.62

0.92

2.3

2.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2.00

0.86

2.0

1.5

—

(3000492) Spirometry study

1.74

0.77

1.2

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

2.24

0.77

1.0

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.15

0.76

1.0

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

172

1.46

0.74

5.3

6.6

1.01

1.04

inr

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

246

1.41

0.73

5.7

3.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.98

0.72

1.4

1.0

0.49

6.11

u/ml

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.98

0.72

1.2

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.69

0.68

1.3

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

287

1.37

0.68

3.1

2.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.64

0.67

5.7

2.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.71

0.62

1.2

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

224

1.37

0.62

1.3

1.4

1.78

1.95

g/l

0.47

119

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.64

0.62

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.61

0.0

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.61

0.0

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

541

1.37

0.61

11.4

6.8

106.21

102.77

ml/min/173m2

0.58

389

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.60

0.0

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1.77

0.59

6.0

12.8

5.88

6.54

mmol/l

—

(3022621) pH of Urine by Test strip

1.67

0.57

8.7

2.1

—

(1761868) Lipid panel - Serum or Plasma

211

0.70

0.56

2.3

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

343

1.31

0.55

2.7

2.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.48

0.54

1.2

1.6

—

(3013512) EKG study

1.47

0.52

3.8

3.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

138

1.39

0.51

1.8

2.5

0.47

1.04

mg/l

1.59

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.53

0.49

1.6

3.1

4.30

4.95

pmol/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

267

0.76

0.45

2.0

1.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.41

0.0

1.8

—

6.28

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.39

0.40

2.2

2.3

—

(3029937) Albumin [Presence] in Urine by Test strip

181

1.29

0.40

7.1

3.0

0.00

0.01

estimate

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

173

1.28

0.37

1.9

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

155

0.74

0.37

1.7

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.60

0.37

1.4

—

(3008898) HLA-B27 [Presence]

1.50

0.37

1.0

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.33

0.34

4.7

11.8

21.42

25.21

mmol/l

—

(3012516) Albumin [Mass/volume] in Urine

102

1.32

0.32

5.0

3.6

187.88

77.15

mg/l

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1.27

0.30

1.1

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

255

1.21

0.29

1.4

1.00

1.14

u/ml

—

(3020682) Albumin/Creatinine [Ratio] in Urine

104

1.30

0.28

5.4

4.3

27.69

16.88

mg/mmol

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.68

0.27

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.28

0.27

1.0

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.37

0.24

2.6

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.37

0.24

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

104

0.75

0.22

1.3

1.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.21

0.0

2.8

—

3.46

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.21

0.0

2.9

—

54.27

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.26

—

(3000991) Gas panel - Venous blood

1.27

0.21

12.3

11.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.20

0.0

1.2

—

(3012544) pH of Venous blood

1.23

0.19

8.3

9.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

667

1.18

0.18

15.2

9.2

18.91

20.53

mg/l

0.19

473

(3017143) Hepatitis C virus Ab [Presence] in Serum

139

1.19

0.18

1.4

—

(40761536) Microorganisms panel - Urine sediment

0.73

0.17

5.0

2.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

192

1.12

0.12

4.6

2.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.12

0.10

1.6

12.4

105.80

104.38

mmol/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.08

0.08

1.9

1.5

—

(3002256) Pathology report gross observation

1.08

0.08

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1.08

0.08

1.9

1.5

—

(3003694) ABO and Rh group [Type] in Blood

265

0.92

0.08

2.3

1.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.03

0.08

1.9

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.80

0.08

1.2

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.86

0.07

1.8

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

170

0.93

0.04

1.7

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

265

0.97

0.00

2.1

1.8

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

7.40

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

11.33

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

-0.00

0.0

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

-0.00

0.0

4.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

0.00

-0.00

0.0

2.5

—

0.67

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

-0.00

0.0

1.0

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

4.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

126.90

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

15.60

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.22

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.19

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.00

-0.00

1.8

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1633.50

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(21494755) Public health laboratory ask at order entry panel

0.92

-0.00

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

0.00

-0.00

0.0

10.7

—

59.00

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.00

-0.00

1.8

1.5

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3049717) Cytology report of Urine Cyto stain

0.00

-0.00

0.0

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

-0.00

0.0

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.00

-0.00

1.8

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

9.56

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.00

-0.00

1.8

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(36660697) Celiac disease serology panel - Serum

0.99

-0.00

1.4

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

35800.00

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SLEEPTERRORS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_SLEEPTERRORS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: F5_SLEEPTERRORS – Sleep terrors [night terrors]

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sleep terrors [night terrors]

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints